Overview

Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas

Status:
Completed

Trial end date:
2009-02-01

Target enrollment:

Participant gender:

Summary

The main purpose of this study is to determine the short and long term side effects of a very intensive treatment, which includes combinations of chemotherapy drugs followed by radiation therapy and two transplants supported by peripheral blood progenitor cells (stem cells), for children with advanced stage neuroblastoma and sarcomas.

Phase:

Phase 2

Details

Lead Sponsor:

Dana-Farber Cancer Institute

Collaborators:

Boston Children's Hospital
Boston Children’s Hospital
Children's Hospital of Philadelphia

Treatments:

Carboplatin
Cyclophosphamide
Doxorubicin
Etoposide
Ifosfamide
Lenograstim
Melphalan
Sargramostim
Vincristine